Search Target

Interdisciplinary Collaboration Grants Program

The Division of Research established the Interdisciplinary Collaboration Grants (ICG) Program to provide funds to facilitate the development of collaborations at Binghamton University. This program is for investigators who seek to enhance their research opportunities through collaboration and may include projects that represent a new research agenda. Proposals from all areas of scholarship are encouraged.

Two projects received funding in the program's 2018-2019 round of awards:

"Antibiotic Use for Urinary Tract Infection Prophylaxis Among Residents in Long-Term Care Faclities"

Principal Investigators and Departments: 

Wesley Kufel (Pharmacy), Ann Myers (Nursing), Gail Rattinger (Pharmacy),
Nicole Zhang (Nursing) and Leon Cosler (Nursing)


Urinary tract infections (UTI) are the second most common infection among long-term care (LTC) residents. Antibiotics are prescribed for UTI treatment, yet their role in prophylaxis is not well-established. The extent to which antibiotics are prescribed for UTI prophylaxis and their impact on clinical outcomes is not well-known. Therefore, we will describe the prevalence and patterns of antibiotic use for UTI prophylaxis among LTC residents. We will also investigate the impact of antibiotic use for UTI prophylaxis on health outcomes such as hospitalizations. We will accomplish this by combining large-scale datasets from the Centers for Medicaid and Medicare Services, specifically LTC patient data and Medicare hospital, prescriber, and prescription data. Our interdisciplinary team consists of experienced pharmacy and nursing faculty with requisite skills and experience to conduct this research. Our pharmacy investigators have expertise in pharmacoepidemiology, large-scale database analyses, and infectious diseases whereas our nursing investigators have expertise with the use and interpretation of the LTC dataset utilized in this research. Our results will characterize current antibiotic practices for UTI prophylaxis among LTC residents. This program will allow us to complete a preliminary analysis that will position us to seek additional funding from sources including NIH, PCORI, or AHRQ.


"Measuring the Global Impact of Preventable Diseases"

Principal Investigators and Departments:

Nicole Hassoun (Philosophy), Leon Cosler (Pharmacy) and
Mark Zhang (Computer Science

In low-income countries around the world, millions suffer from neglected tropical diseases (NTDs) due to lack of sufficient drug development. To change this paradigm, we propose a new way of thinking about drug procurement using data to develop an aggregate composite score that assesses the population health impact of drugs on the global burden of disease, assessing the affordability of the drug relative to other treatments, and the social impact of the drug manufacturer. In order to expand
access to treatment, it is important to measure life-saving drugs' impact on these diseases. To this end, the current interdisciplinary research will work to expand a searchable index of pharmaceutical data, providing information on medications for these diseases' health consequences by drug, country, disease, and company, allowing policymakers and the general public to easily identify the beneficial drugs and how they are impacting the local community. To date, several countries, drugs, and pharmaceutical companies have been ranked on their impact on reducing healthcare inequalities. The final project for this grant is to evaluate the impact of drugs available to treat TB, HIV/AIDS, and malaria, and add four NTDs to the drug impact index, publish papers on this topic, and present findings.

Last Updated: 7/9/18